Gilteritinib as Post-Transplant Maintenance for AML with Internal Tandem Duplication Mutation of FLT3
Mark J. Levis, Mehdi Hamadani, Brent Logan, Richard J. Jones, Anurag K. Singh, Mark Litzow, John R. Wingard, Esperanza B. Papadopoulos, Alexander E. Perl, Robert J. Soiffer, Celalettin Ustun, Masumi Ueda Oshima, Geoffrey L. Uy, Edmund K. Waller, Sumithra Vasu, Melhem Solh, Asmita Mishra, Lori Muffly, Hee Je Kim, Jan Henrik MikeschYuho Najima, Masahiro Onozawa, Kirsty Thomson, Arnon Nagler, Andrew H. Wei, Guido Marcucci, Nancy L. Geller, Nahla Hasabou, David Delgado, Matt Rosales, Jason Hill, Stanley C. Gill, Rishita Nuthethi, Denise King, Heather Wittsack, Adam Mendizabal, Steven M. Devine, Mary M. Horowitz, Yi Bin Chen
Dive into the research topics of 'Gilteritinib as Post-Transplant Maintenance for AML with Internal Tandem Duplication Mutation of FLT3'. Together they form a unique fingerprint.